Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nanovibronix Inc (NQ: NAOV )

0.7200 -0.0001 (-0.01%)
Streaming Delayed Price Updated: 10:16 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nanovibronix Inc

< Previous 1 2 3 Next >
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Partnership with Peak Medical, Ltd.
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Interim Results of Clinical Study for UroShield
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Sets Date for Annual Shareholder Meeting
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Webinar Series to Promote UroShield
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Reports First Quarter 2022 Financial Results
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Adds Additional Product to Federal Supply Schedule
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Advances Efforts to Achieve NHS Approval
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
From NanoVibronix Inc.
Via Business Wire
NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion
From NanoVibronix Inc.
Via Business Wire
NanoVibronix Reports Third Quarter 2021 Financial Results
From NanoVibronix, Inc.
Via Business Wire
SANUWAVE Inc. Assets Get Another Valuation Boost Following NanoVibronix Making Shockwave Therapy Available OTC (OTC: SNWV)
Via AB Newswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.